Algonaid Omer A, Almoukirish Abdulrahman S, Almashham Yahya H
King Salman Heart Center, King Fahad Medical City, P.O.box 59046, Riyadh 11525, Saudi ArabiaSaudi Arabia.
J Saudi Heart Assoc. 2019 Jan;31(1):9-11. doi: 10.1016/j.jsha.2018.08.004. Epub 2018 Sep 28.
Kawasaki disease (KD) is a potentially decapacitating multisystemic vasculitis with unknown etiology that acquired worldwide attention due to associated coronary aneurysms leading to life-threatening complications in very young babies including thrombosis, ischemia, and rupture. High levels of suspicion for early diagnosis and prompt treatment are crucial in preventing serious complications. We report here one of the patients who developed a giant coronary aneurysm but fortunately not a life-threatening complication after 5 years of follow-up. We conclude that later intravenous immunoglobulins (IVIG) treatment could be an important factor-among others-that precipitate into such complications.
川崎病（KD）是一种病因不明的潜在致残性多系统血管炎，由于相关冠状动脉瘤可导致非常年幼婴儿出现危及生命的并发症，包括血栓形成、缺血和破裂，因而受到全球关注。高度怀疑以便早期诊断并及时治疗对于预防严重并发症至关重要。我们在此报告一名患者，该患者出现了巨大冠状动脉瘤，但幸运的是，经过5年随访未出现危及生命的并发症。我们得出结论，在导致此类并发症的诸多因素中，后期静脉注射免疫球蛋白（IVIG）治疗可能是一个重要因素。
